@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAhOGzPh43t0qrYGDm5AzBzA0kLOW8tz2AhAjCQ0AB1n4> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAhOGzPh43t0qrYGDm5AzBzA0kLOW8tz2AhAjCQ0AB1n4#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix hasPart: <http://purl.obolibrary.org/obo/BFO_0000051> .
@prefix ProteinComplex: <http://amigo.geneontology.org/amigo/term/GO:0043234> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 hasPart: hgnc:5981, sub:_2;
    occursIn: obo:CL_0000842, species:9606;
    a ProteinComplex: .
  
  sub:_2 geneProductOf: hgnc:9955;
    a Protein: .
  
  sub:assertion rdfs:label "complex(p(HGNC:RELA),g(HGNC:IL17A))" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_4;
    pav:version "20131211" .
  
  sub:_3 prov:value "Incubation of nuclear extracts from peripheral blood mononuclear cells with anti-CD23 plus CD28 demonstrated increased binding of NFKB to IL17 promoters with shifted bands in p50 and p65. But treatment with LY294002 and PTDC, inhibitors of PI3K and NFkB, completely blocked the NFkB binding activity in the IL-17 promoter, indicating that CD3 and CD28 induced the translocation of p50-NFkB and increased its binding with the IL-17 promoter.";
    prov:wasQuotedFrom pubmed:15642134 .
  
  sub:_4 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:15642134;
    prov:wasDerivedFrom beldoc:, sub:_3 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:32:37.452+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}